Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sunscreen TEA Review Deadlines In Limbo In House, Default Approvals Cut

This article was originally published in The Tan Sheet

Executive Summary

The House Energy and Commerce Health subcommittee unanimously advances the Sunscreen Innovation Act to full committee, but provisions in the bill seeking a tight timeline for FDA’s review of sunscreen ingredient TEAs are in limbo, according to the Public Access to Sunscreens coalition of stakeholders.

You may also be interested in...



FDA Faults BASF Sunscreen Ingredient Data In Latest TEA Rejection

FDA advises BASF that the information the firm submitted is not sufficient to establish octyl triazone as GRASE. The agency’s third rejection this year of a sunscreen TEA could concern advocates on Capitol Hill and in the industry for using the process for adding ingredients to the OTC sunscreen monograph.

FDA Sunscreen Decision Deadlines, Expedited TEAs Proposed

The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.

Ulta: ‘Natural Look’ Trend Slowing Makeup Sales, But Offers Room To Innovate

With color cosmetics sales on the decline in the US, retailer Ulta Beauty is confident marketers can inject some excitement and innovation into the category, but acknowledges the shift may take some time.

Topics

Related Companies

UsernamePublicRestriction

Register

PS107002

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel